SCHEMBL18800563

SCHEMBL18800563

COc1cccc(-c2cnc(Nc3ccccc3)c(N)c2C(=N)N)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 2/20 0.58
▸ CYP1A2 P05177 6/20 0.56
▸ CYP3A4 P08684 5/20 0.56
▸ MAPK1 P28482 5/20 0.56
▸ CYP2C19 P33261 5/20 0.56
▸ CYP2D6 P10635 4/20 0.56
▸ HSD17B10 Q99714 3/20 0.56
▸ ADORA2A P29274 2/20 0.48
▸ ADORA1 P30542 2/20 0.48
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ CLK4 Q9HAZ1 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ TSHR P16473 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ BRAF P15056 1/20 0.47
▸ ALOX15 P16050 1/20 0.46
▸ PDE4B Q07343 1/20 0.44
▸ PRKDC P78527 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800468 0.87 BTK (0.49) BTKCYP1A2CYP3A4MAPK1CYP2C19
SCHEMBL18800760 0.86 BTK (0.61) BTKCYP1A2CYP3A4MAPK1CYP2C19
SCHEMBL18800786 0.85 RAPGEF4 (0.44) BTKCYP1A2CYP3A4MAPK1CYP2C19
SCHEMBL18800466 0.83 DHODH (0.42) BTKCYP1A2CYP3A4MAPK1CYP2C19
SCHEMBL18800792 0.77 BTK (0.47) BTKADORA2AADORA1LMNAFGFR1
SCHEMBL18800769 0.77 ADORA2A (0.48) BTKMAPK1HSD17B10ADORA2AADORA1
SCHEMBL18800891 0.76 BTK (0.62) BTKADORA2AADORA1MEN1KMT2A
SCHEMBL18800784 0.75 BTK (0.46) BTKADORA2AADORA1ATRDYRK1A
SCHEMBL18800559 0.74 BTK (0.58) BTKMAPK1MEN1KMT2ATSHR
SCHEMBL6115583 0.74 BTK (1.00) BTKCYP1A2CYP3A4MAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback